As the volume and complexity of clinical trial data grows, scientists need new ways to filter information. Elly Earls speaks to SAFE Bio-Pharma's Mollie Shields-Uehling and IBM's Chris Hines about why moving to the cloud could reduce clinical trial costs, accelerate innovation and ultimately improve patient care.
Cloud computing allows companies to avoid building their own IT infrastructure. Instead, a third party provides an online platform or 'cloud' on which members of a particular organisation who have the necessary security clearance, as well as their collaborators in different locations, can share resources, software and information.
Showing posts with label cloud-based clinical trial. Show all posts
Showing posts with label cloud-based clinical trial. Show all posts
Monday, March 26, 2012
Ahead in the cloud – a new home for clinical trial data - Pharmaceutical Technology
Ahead in the cloud – a new home for clinical trial data - Pharmaceutical Technology
Trusted Identities for Cloud Collaboration, June 24, 2012
DIA 2012 Collaborate to Innovate
48th Annual Meeting
June 24-28, 2012
Philadelphia, PA
Pennsylvania Convention Center
Trusted Identities for Cloud Collaboration: How Standards Accelerate Collaboration In The Cloud
Sunday, June 24, 2012
9:00 AM - 6:30 PM
Pennsylvania Convention Center
This seminal conference co-hosted by DIA and SAFE-BioPharma® provides a deep dive into the use of standardized identity trust to improve speed, cost, and efficiency in cloud collaboration.
Featured Topics:
- ePatient trial data entry using trusted digital identities and iPads
- Cloud-based clinical trial initiation
- ePrescribing
- Digital signing and exchange of adverse events
- eSubmissions
- Electronic laboratory notebooks
Register Today
Program Chairperson
Mollie Shields-Uehling
President and CEO
SAFE-BioPharma®
Mollie Shields-UehlingPresident and CEO
SAFE-BioPharma®
Learning Objectives:
Attendees of this meeting will be able to
- Describe standards-based interoperable digital identities and the essential uses in biopharmaceuticals and healthcare
- Explain benefits and obstacles associated with introducing and using this technology
- Identify the spectrum of current and future applications for standards-based interoperable digital identities and digital signatures
- Discuss the practical use of standards-based interoperable digital identities and digital signatures within organizations.
Please click for Agenda
Registration Fees
$755 includes access to "Trusted Identities for Cloud ollaboration," refreshment breaks, and lunch.
Save $200 when you register for both "Trusted Identities for Cloud Collaboration" and DIA 2012.*
Register Today
Application & Contract for Table Top Display
* Both purchases must be made at the same time to receive the discount.
About SAFE-BioPharma®
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
Homepage
© 2011 DIA | Home | diahome.org | Site Map | Contact Us | Disclaimer | Privacy Policy
Subscribe to:
Posts (Atom)